ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

November issue of Business & Regulatory Report included.

November 28, 2003

Program Announcement In Preventative Oncology

May 21, 1982

DeVita: No Decision Yet On FCRF Award

July 17, 1987

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980